Share-based Payment Arrangement, Expense of TFF Pharmaceuticals, Inc. from 30 Jun 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TFF Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2018 to 30 Sep 2024.
  • TFF Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $567,672, a 26% decline year-over-year.
  • TFF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $590,041, a 291% increase from 2018.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TFF Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $567,672 -$198,647 -26% 01 Jul 2024 30 Sep 2024 10-Q 20 Nov 2024 2024 Q3
Q2 2024 $608,352 -$217,367 -26% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q3 2023 $766,319 -$189,242 -20% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2024 2024 Q3
Q2 2023 $825,719 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q3 2022 $955,561 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q3 2020 $1,478,755 $546,120 +$775,136 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $703,619 $295,356 -$191,040 -39% 01 Apr 2020 30 Jun 2020 10-Q 05 Nov 2020 2020 Q3
Q1 2020 $894,659 $425,844 +$304,618 +251% 01 Jan 2020 31 Mar 2020 10-Q 05 Nov 2020 2020 Q3
Q4 2019 $590,041 $211,435 01 Oct 2019 31 Dec 2019 10-K 27 Mar 2020 2019 FY
Q3 2019 $229,016 -$291,122 -469% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $486,396 -$687,444 -59% 01 Apr 2019 30 Jun 2019 10-Q 05 Nov 2020 2020 Q3
Q1 2019 $121,226 01 Jan 2019 31 Mar 2019 10-Q 05 Nov 2020 2020 Q3
Q3 2018 $62,106 01 Jul 2018 30 Sep 2018 10-Q 09 Dec 2019 2019 Q3
Q2 2018 $1,173,840 01 Apr 2018 30 Jun 2018 10-Q 09 Dec 2019 2019 Q3

TFF Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2019 $590,041 +$439,055 +291% 01 Jan 2019 31 Dec 2019 10-K 27 Mar 2020 2019 FY
2018 $150,986 24 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.